SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-322696
Filing Date
2018-11-08
Accepted
2018-11-08 17:12:06
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d636603d10q.htm 10-Q 772372
2 EX-31.1 d636603dex311.htm EX-31.1 6192
3 EX-31.2 d636603dex312.htm EX-31.2 6229
4 EX-32.1 d636603dex321.htm EX-32.1 3798
5 EX-32.2 d636603dex322.htm EX-32.2 3875
  Complete submission text file 0001193125-18-322696.txt   3797448

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20180930.xml EX-101.INS 605147
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20180930.xsd EX-101.SCH 42399
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20180930_cal.xml EX-101.CAL 55704
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20180930_def.xml EX-101.DEF 198454
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20180930_lab.xml EX-101.LAB 366243
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20180930_pre.xml EX-101.PRE 293067
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 181170572
SIC: 2834 Pharmaceutical Preparations